Difference between revisions of "Christopher Gent"

From Powerbase
Jump to: navigation, search
 
Line 1: Line 1:
[[File:Sir Christopher Gent Flickr.jpg|right|300px|''Christopher Gent'' 22 January 2013]] Sir '''Christopher Gent''' (10 May 1948) is the former CEO of [[Vodaphone]] and the current chairman of [[GlaxoSmithKline]].
+
[[File:Sir Christopher Gent Flickr.jpg|right|thumb|300px|''Christopher Gent'' 22 January 2013]] Sir '''Christopher Gent''' (10 May 1948) is the former CEO of [[Vodaphone]] and the current chairman of [[GlaxoSmithKline]].
  
 
==Career==
 
==Career==
In 1985, Gent joined [[Vodaphone]] managing director of UK network, in 1988 he became a board member and in 1997 he became CEO. Whilst CEO he increased [[Vodaphone]]'s market value from £7.5billion to £77billion. He stepped down from his role [[Vodaphone]] in July 2003.<ref> Tim Weber [http://news.bbc.co.uk/1/hi/business/2586347.stm Christopher Gent profile] ''The BBC'', 18 December, 2002, accessed 25 September 2014 </ref>
+
In 1985 Gent joined [[Vodaphone]] managing director of UK network, in 1988 he became a board member and in 1997 he became CEO. Whilst CEO he increased [[Vodaphone]]'s market value from £7.5billion to £77billion. He stepped down from his role [[Vodaphone]] in July 2003.<ref> Tim Weber [http://news.bbc.co.uk/1/hi/business/2586347.stm Christopher Gent profile] ''The BBC'', 18 December, 2002, accessed 25 September 2014 </ref>
  
In 2004 he joined pharmaceutical company [[GlaxoSmithKline]] and became chairman in 2005. He announced in 2012 he would be stepping down within the next two to three years.<ref> Telegraph Staff [http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9639020/Sir-Christopher-Gent-to-exit-GlaxoSmithKline.html Sir Christopher Gent to exit GlaxoSmithKline] ''The Telegraph'', 28 Oct 2012, accessed 25 September 2014 </ref>
+
In 2004 he joined pharmaceutical company [[GlaxoSmithKline]], becoming chairman in 2005. He announced in 2012 he would step down within the next two to three years.<ref> Telegraph Staff [http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9639020/Sir-Christopher-Gent-to-exit-GlaxoSmithKline.html Sir Christopher Gent to exit GlaxoSmithKline] ''The Telegraph'', 28 Oct 2012, accessed 25 September 2014 </ref>
  
 
In 2005, he featured as part of [[George Osborne]]'s tax reform commission, looking at the introduction of a flat tax scheme. <ref> James Blitz [http://www.ft.com/cms/s/0/4621b0ec-3abc-11da-b0d3-00000e2511c8.html#axzz3EKY5HfI4 Osborne outlines plans for tax reform commission] ''The Financial Times'', 12 October 2005, accessed 25 September 2014 </ref>
 
In 2005, he featured as part of [[George Osborne]]'s tax reform commission, looking at the introduction of a flat tax scheme. <ref> James Blitz [http://www.ft.com/cms/s/0/4621b0ec-3abc-11da-b0d3-00000e2511c8.html#axzz3EKY5HfI4 Osborne outlines plans for tax reform commission] ''The Financial Times'', 12 October 2005, accessed 25 September 2014 </ref>
  
He was a director of [[Hakluyt]]'s international advisory board [[The Holdingham Group Advisory Board]] from 1 February 2004 to 31 January 2006.
+
Gent was a director of [[Hakluyt]]'s international advisory board [[The Holdingham Group Advisory Board]] from 1 February 2004 until 31 January 2006.
  
 
==Notes==
 
==Notes==

Latest revision as of 05:56, 30 September 2014

Christopher Gent 22 January 2013

Sir Christopher Gent (10 May 1948) is the former CEO of Vodaphone and the current chairman of GlaxoSmithKline.

Career

In 1985 Gent joined Vodaphone managing director of UK network, in 1988 he became a board member and in 1997 he became CEO. Whilst CEO he increased Vodaphone's market value from £7.5billion to £77billion. He stepped down from his role Vodaphone in July 2003.[1]

In 2004 he joined pharmaceutical company GlaxoSmithKline, becoming chairman in 2005. He announced in 2012 he would step down within the next two to three years.[2]

In 2005, he featured as part of George Osborne's tax reform commission, looking at the introduction of a flat tax scheme. [3]

Gent was a director of Hakluyt's international advisory board The Holdingham Group Advisory Board from 1 February 2004 until 31 January 2006.

Notes

  1. Tim Weber Christopher Gent profile The BBC, 18 December, 2002, accessed 25 September 2014
  2. Telegraph Staff Sir Christopher Gent to exit GlaxoSmithKline The Telegraph, 28 Oct 2012, accessed 25 September 2014
  3. James Blitz Osborne outlines plans for tax reform commission The Financial Times, 12 October 2005, accessed 25 September 2014